Oregon Health & Science University
People
Professor and director of research
Professor, department of medicine
Siyu Chen
Assistant professor
Assistant professor
Associate professor
Professor
Graduate research assistant
Associate professor
Professor
Post doctoral research fellow
Associate professor
Professor
Cirila Estela Vasquez Guzman
Assistant professor
Professor
Assistant professor
Professor and chair
Sarah Lusk
Postdoctoral scholar
Sources: reporter.nih.gov
Trials
Sotatercept in the Treatment of Methamphetamine-Associated Pulmonary Arterial Hypertension
Phase 4, Not yet recruiting, 20 people
Not yet recruiting, 26 people
Collaborator, Not yet recruiting, 200 people
Collaborator, Phase 4, Recruiting, 58 people, Oct 5, 2026
Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder
Collaborator, Phase 1, Recruiting, 6 people, Sep 28, 2026
Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum
Phase 2, Recruiting, 12 people, Aug 24, 2026
Phase 2, Not yet recruiting, 15 people, Aug 17, 2026
Phase 4, Not yet recruiting, 170 people, Jul 6, 2026
Phase 4, Recruiting, 40 people, May 20, 2026
Phase 2, Not yet recruiting, 57 people, May 18, 2026
Collaborator, Phase 1, Recruiting, 40 people, Apr 23, 2026
Collaborator, Phase 2, Not yet recruiting, 40 people, Apr 6, 2026
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
Collaborator, Recruiting, 150 people, Apr 1, 2026
Mammogram Pretreatment With Ulipristal Acetate
Collaborator, Phase 2, Recruiting, 26 people, Feb 25, 2026
Cefotetan Therapy for Escherichia Coli Infections
Phase 2, Recruiting, 50 people, Jan 6, 2026
Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia
Phase 4, Not yet recruiting, 50 people, Dec 19, 2025
Collaborator, Recruiting, 36 people, Dec 12, 2025
Collaborator, Phase 2, Recruiting, 102 people, Nov 14, 2025
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
Recruiting, 38 people, Sep 17, 2025
Phase 1, Recruiting, 15 people, May 23, 2025
Sources: clinicaltrials.gov
Grants and prizes
R01, GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia, R01AG079890, $778K, 2026–2028, Sep 15, 2026
R01, Neuroinflammatory Mechanisms of Vascular Cognitive Impairment, R01AG058273, $536K, 2017–2028, Sep 15, 2026
Contribution of endothelin 1 mediated ischemic vascular dysfunction to Alzheimer's disease, F30AG089943, $55.1K, Sep 4, 2026
National Institute of Child Health and Human Development
R01, Impact of semaglutide on maternal-fetal health outcomes, R01HD122906, $753K, 2026–2031, Sep 1, 2026
R01, Novel ultrahigh resolution OCT biomarkers in age-related macular degeneration, R01EY039313, $498K, 2026–2030, Aug 31, 2026
National Heart, Lung, and Blood Institute
K01, Leveraging Informatics to Optimize Cardiovascular Risk Prediction in Women, K01HL177176, $186K, 2025–2028, Aug 31, 2026
National Institute on Minority Health and Health Disparities
R01, American Indian/Alaska Native Tailoring of a Home-Based Cervical and Colorectal Cancer Screening Program (AT-HOME), R01MD021852, $3.1M, 2026–2030, Aug 28, 2026
R33, Advancing Capacity to Integrate Exercise into the Care of Older Cancer Survivors: The ACES initiative to establish guidelines, feasibility and best practices for research in cancer and aging, R33CA280996, $546K, 2023–2028, Aug 18, 2026
Secondary analyses of results from a randomized clinical trial to improve sleep in a cohort at high risk for Alzheimers Disease and related dementias, F31AG099370, $50.1K, Aug 18, 2026
National Institute of Neurological Disorders and Stroke
R01, Pericyte phenotypic switching in diabetic post-stroke cognitive impairment (PSCI), R01NS146933, $594K, 2026–2031, Aug 14, 2026
National Heart, Lung, and Blood Institute
R01, Uncovering sleep and circadian mechanisms contributing to adverse metabolic health, R01HL169317, $570K, 2023–2027, Aug 14, 2026
National Institute on Deafness and Other Communication Disorders
R01, The role of vascular endothelial growth factor signaling in normal hearing andaging-related cochlear atrophy, R01DC018534, $529K, 2020–2031, Aug 12, 2026
National Center for Complementary and Alternative Medicine
K08, Network models to capture multiple outcomes resulting from multi-component, salutogenic interventions, K08AT012477, $155K, 2023–2028, Aug 6, 2026
National Institute of Neurological Disorders and Stroke
R01, Astrocyte regulation of cerebral blood flow at the intersection of ischemia and Alzheimer's disease, R01NS134592, $660K, 2023–2028, Aug 4, 2026
RF1, Role of ferroptosis of oligodendrocytes and vascular endothelial cells in vascular and Alzheimer's Disease related dementia, RF1AG098171, $3.4M, 2026–2030, Jul 31, 2026
K01, Assess and Design a Multi-level Intervention with Middle to Older Age Mexican Immigrants to Increase Cervical Cancer Screening in Community Health Clinics, K01CA292141, $177K, 2024–2029, Jul 31, 2026
National Heart, Lung, and Blood Institute
R01, Inflammation-Driven Clonal Evolution in RUNX1 Carriers: Mechanisms and Therapeutic Vulnerabilities, R01HL155426, $611K, 2021–2030, Jul 27, 2026
R33, The Pacific Aging and Cancer Studies (PACS): An Infrastructure Advancing the Use of Digital Biomarkers and Related Technologies for Research on Functional Aging and Survivorship in Cancer, R33CA280994, $646K, 2023–2028, Jul 21, 2026
National Institute on Deafness and Other Communication Disorders
R13, Annual Meeting of the Population Hearing Health Care (PopHHC) Network, R13DC020098, $59.7K, 2021–2028, Jul 17, 2026
K23, Longitudinal Characterization of Nutritional Behavior Using Unobtrusive Digital Technology in Aging, Alzheimer's and Related Disorders, K23AG071793, $154K, 2022–2027, Jul 17, 2026
Sources: reporter.nih.gov
Funded papers
Mouse APOE Christchurch protects against Aβ-induced tau and α-synuclein aggregation
Nov 10, 2026
Metformin and Severe Post‐ COVID ‐19 Outcomes Among Individuals With Diabetes Mellitus
Nov 5, 2026
Sleep: And then there was light!
Nov 1, 2026
Oct 5, 2026
Aug 19, 2026
Aug 12, 2026
Imaging-based biological age estimation predicts competing mortality risk in lung cancer screening
Aug 10, 2026
SCR_009961, Jul 24, 2026
May 24, 2026
Characterising Multimorbidity in Adults With Heart Failure: A Latent Class Analysis
May 15, 2026
Mar 23, 2026
Association of Progressive PPFE and Mortality in Lung Cancer Screening Cohorts
Mar 10, 2026
Diet, gut microbiome, and cognition in neurodegeneration: a review and methodological framework
Mar 4, 2026
Moderate Aerobic Training Causes Muscle Wasting in a DMBA-Induced Sarcoma Rat Model
P30CA069533, Mar 4, 2026
Engineered muscle drives bone repair and functional healing after composite musculoskeletal injury
Feb 9, 2026
Jan 31, 2026
Jan 21, 2026
Variation in prostate cancer growth rates in an MRI-based active surveillance cohort
Jan 16, 2026
Jan 1, 2026
Dec 23, 2025
Sources: openalex.org, api.crossref.org
Named in competing interests
Cortical thickness as predictor of response to exercise in people with Parkinson's disease
Board or leadership role, Oct 9, 2020
Deep Learning to Assess Long-term Mortality From Chest Radiographs
Grants or research support, Jul 3, 2019
Sources: pubmed.ncbi.nlm.nih.gov
Papers
Cancer-focused training improves predictions from health records
Research Square, Nov 20, 2026
Agent Orange exposure linked to Parkinson disease in US veterans
JAMA neurology, Nov 16, 2026
Brain scan model performs best in dementia detection tests
Communications medicine, Nov 13, 2026
Cancer, Nov 12, 2026
Biomarker use in the prostate cancer screening pathway: Maps of the evidence
Cancer, Nov 12, 2026
Oral semaglutide reduced total major cardiovascular events
JAMA cardiology, Nov 11, 2026
...International Conference on Indoor Air Quality, Ventilation & Energy Conservation in Buildings. International Conference on Indoor Air Quality, Ventilation & Energy Conservation in Buildings, Nov 11, 2026
Gene change reduced dementia-linked protein clumps in mice
Cell reports, Nov 10, 2026
Artificial Intelligence‒Guided Phenotyping of Cardiomyopathies: From Detection to Surveillance
Journal of cardiac failure, Nov 10, 2026
Diabetes drugs linked to lower death risk in vascular dementia
Acta neurologica Belgica, Nov 10, 2026
International journal of cancer, Nov 10, 2026
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
Inflammation protein may help refine heart disease risk estimates
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
Heart failure model predicted risk well overall in US veterans
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
Diabetes drugs linked to lower dementia risk after minor stroke
Journal of neurology, Nov 7, 2026
The Journal of clinical endocrinology and metabolism, Nov 6, 2026
The British journal of nutrition, Nov 6, 2026
RNA changes with age differ by sex in rhesus macaque brains
bioRxiv, Nov 6, 2026